How Do Regulatory Agencies Evaluate Cancer Treatments?
Regulatory agencies evaluate cancer treatments through a rigorous process that includes preclinical studies, clinical trials (Phase I, II, III), and post-marketing surveillance. These steps involve assessing the treatment's mechanism of action, dosage, side effects, and overall efficacy. Agencies also consider real-world evidence and patient-reported outcomes to make well-rounded decisions.
